第 1 到 115 筆結果,共 115 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer | KUO-HSING CHEN ; CHIA-LANG HSU ; Su, Yu-Li; CHANG-TSU YUAN ; LIANG-IN LIN ; JIA-HUEI TSAI ; YI-HSIN LIANG ; ANN-LII CHENG ; KUN-HUEI YEH | British journal of cancer | 0 | 0 | |
2 | 2022 | Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; CHUNG-WU LIN ; JYH-MING LIOU ; MING-SHIANG WU ; Chen, Li-Tzong; ANN-LII CHENG | Cancers | 9 | 8 | |
3 | 2021 | Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling | SUNG-HSIN KUO ; SHIH-HUNG YANG ; Wei, Ming-Feng; Lee, Hsiao-Wei; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH | Cancer cell international | 3 | 3 | |
4 | 2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | KUO-HSING CHEN ; LIANG-IN LIN ; CHANG-TSU YUAN ; LI-HUI TSENG ; Chao, Yu-Liang; YI-HSIN LIANG ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | British journal of cancer | 0 | 0 | |
5 | 2021 | Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma | SHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH | Oncoimmunology | 3 | 4 | |
6 | 2021 | Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas | WEI-LI MA ; KUN-HUEI YEH ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; Wang Y.-T.; Yeh Y.-C.; HSIU-PO WANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of the Formosan Medical Association | 5 | 3 | |
7 | 2020 | Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients | SHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH | Journal of the Formosan Medical Association | 3 | 3 | |
8 | 2020 | A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue | Tsai H.-J.; Tai J.J.; Chen L.-T.; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; Wang T.-E.; HSIU-PO WANG ; Yu F.-J.; JYH-MING LIOU ; Hsiao C.-F.; TSU-YAO CHENG ; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN ; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; SUNG-HSIN KUO ; ANN-LII CHENG | Haematologica | 5 | 5 | |
9 | 2019 | Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; MING-SHIANG WU ; KUN-HUEI YEH ; CHUNG-WU LIN ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG | Cancers | 21 | 22 | |
10 | 2019 | Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma | Ta-Chen Huang ; CHIA-CHI LIN ; Wu Y.-C.; CHIA-HSIEN CHENG ; JANG-MING LEE ; HSIU-PO WANG ; PEI-MING HUANG ; Feng-Ming Hsu ; KUN-HUEI YEH ; ANN-LII CHENG ; KAI-YUAN TZEN ; CHIH-HUNG HSU | Journal of the Formosan Medical Association | 8 | 6 | |
11 | 2019 | CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer | KUO-HSING CHEN ; LIANG-IN LIN ; LI-HUI TSENG ; Lin, Yu-Lin; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | Oncology | 6 | 4 | |
12 | 2018 | A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma | SHIH-HUNG YANG ; YU-YUN SHAO ; CHIA-CHI LIN ; SUNG-HSIN KUO ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 3 | 2 | |
13 | 2017 | Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study | YI-HSIN LIANG ; YU-YUN SHAO ; Chen, Ho Min; ANN-LII CHENG ; Lai, Mei Shu; KUN-HUEI YEH | Anticancer Research | 10 | 11 | |
14 | 2017 | Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer | Tsai K.-F.; JYH-MING LIOU ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; SUNG-HSIN KUO ; I-RUE LAI ; KUN-HUEI YEH ; MING-TSAN LIN ; HSIU-PO WANG ; ANN-LII CHENG ; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | PLoS ONE | 29 | 25 | |
15 | 2017 | Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL | SUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; KUN-HUEI YEH ; CHIA-TUNG SHUN ; Tzeng Y.-S.; JYH-MING LIOU ; MING-SHIANG WU ; PING-NING HSU ; ANN-LII CHENG | Blood | 19 | 16 | |
16 | 2017 | Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy | SHIH-HUNG YANG ; JEN-CHIEH LEE ; JHE-CYUAN GUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; TING-CHUN KUO ; ANN-LII CHENG ; KUN-HUEI YEH | PLoS ONE | 6 | 3 | |
17 | 2017 | First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; Wei M.-F.; JYH-MING LIOU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG | Scientific Reports | 17 | 18 | |
18 | 2017 | The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21) | SUNG-HSIN KUO ; Tsai H.-J.; CHUNG-WU LIN ; KUN-HUEI YEH ; Lee H.-W.; Wei M.-F.; CHIA-TUNG SHUN ; MING-SHIANG WU ; PING-NING HSU ; Chen L.-T.; ANN-LII CHENG | Journal of Pathology | 12 | 12 | |
19 | 2017 | Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer | YI-HSIN LIANG ; Wei, C. H.; Hsu, W. H.; YU-YUN SHAO ; Lin, Y. C.; Chou, P. C.; ANN-LII CHENG ; KUN-HUEI YEH | Support Care Cancer | 10 | 10 | |
20 | 2017 | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | ANN-LII CHENG ; Cornelio G.; Shen L.; Price T.; Yang T.-S.; Chung I.J.; Dai G.-H.; Lin J.-K.; Sharma A.; KUN-HUEI YEH ; Ma B.; Zaatar A.; Guan Z.; Masood N.; Srimuninnimit V.; Yau T.; Gibbs P.; Wang X.; Doval D.C.; Oh S.-T.; Shim B.Y.; Gorospe C.; Wang H.-M.; Sirachainan E.; Hill A.; Suh K.W.; Beier F.; Chatterjee S.; Lim R. | Clinical Colorectal Cancer | 21 | 19 | |
21 | 2016 | Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer | SHIH-HUNG YANG ; TING-CHUN KUO ; Wu H.; JHE-CYUAN GUO ; CHIUN HSU ; CHIH-HUNG HSU ; YU-WEN TIEN ; KUN-HUEI YEH ; ANN-LII CHENG ; SUNG-HSIN KUO | World Journal of Gastroenterology | 24 | 25 | |
22 | 2016 | Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer | SHIH-HUNG YANG ; JHE-CYUAN GUO ; KUN-HUEI YEH ; YU-WEN TIEN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
23 | 2016 | Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study | KUO-HSING CHEN ; YU-YUN SHAO ; Chen H.-M.; Lin Y.-L.; ZHONG-ZHE LIN ; Lai M.-S.; ANN-LII CHENG ; KUN-HUEI YEH | BMC Cancer | 39 | 39 | |
24 | 2016 | BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer | KUO-HSING CHEN ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | Medical Oncology | 19 | 18 | |
25 | 2015 | Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma | JHE-CYUAN GUO ; Ta-Chen Huang ; CHIA-CHI LIN ; MIN-SHU HSIEH ; Chang C.-H.; PEI-MING HUANG ; JANG-MING LEE ; Feng-Ming Hsu ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU | Journal of Thoracic Oncology | 15 | 16 | |
26 | 2015 | Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan | YU-YUN SHAO ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; ZHONG-ZHE LIN ; ANN-LII CHENG ; Lai M.-S. | Clinical Colorectal Cancer | 35 | 32 | |
27 | 2015 | Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations | YI-HSIN LIANG ; Lin Y.-L.; JAU-YU LIAU ; JIA-HUEI TSAI ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LI-HUI TSENG ; LIANG-IN LIN ; YIH-LEONG CHANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 4 | 4 | |
28 | 2015 | Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; MING-SHIANG WU ; JYH-MING LIOU ; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG | American Journal of Surgical Pathology | 16 | 16 | |
29 | 2015 | Young patients with colorectal cancer have increased risk of second primary cancers | YI-HSIN LIANG ; YU-YUN SHAO ; Chen H.-M.; Lai C.-L.; ZHONG-ZHE LIN ; Kuo R.N.; ANN-LII CHENG ; KUN-HUEI YEH ; Lai M.-S. | Japanese Journal of Clinical Oncology | 11 | 11 | |
30 | 2015 | Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients | Chang T.C.; Shiah H.S.; CHIH-HSIN YANG ; KUN-HUEI YEH ; ANN-LII CHENG ; Shen B.N.; Wang Y.W.; Yeh C.G.; Chiang N.J.; Chang J.Y.; Chen L.T. | Cancer Chemotherapy and Pharmacology | 87 | 74 | |
31 | 2014 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers | HSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH | Supportive Care in Cancer | 10 | 10 | |
32 | 2014 | A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies | CHIA-CHI LIN ; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU ; Su W.-P.; KUN-HUEI YEH ; YEN-SHEN LU ; ANN-LII CHENG ; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; CHIH-HSIN YANG | British Journal of Cancer | 62 | 64 | |
33 | 2014 | Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse | SUNG-HSIN KUO ; Tsai H.-J.; Weng W.-H.; Li C.-C.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG | Genes Chromosomes and Cancer | 3 | 3 | |
34 | 2014 | Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer | Ying-Chun Shen ; Li C.-P.; Yen C.-J.; CHIUN HSU ; Lin Y.-L.; ZHONG-ZHE LIN ; Chen L.-T.; Su W.-C.; Chao Y.; KUN-HUEI YEH ; ANN-LII CHENG | Oncology (Switzerland) | 15 | 12 | |
35 | 2014 | Type 2 diabetes mellitus is associated with increased mortality in chinese patients receiving curative surgery for colon cancer | KUO-HSING CHEN ; YU-YUN SHAO ; ZHONG-ZHE LIN ; Yeh Y.-C.; Wen-Yi S.; Kuo R.N.; Chen H.-M.; Lai C.-L.; KUN-HUEI YEH ; ANN-LII CHENG ; Lai M.-S. | Oncologist | 24 | 19 | |
36 | 2014 | Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity | SUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; CHIUN HSU ; MING-SHIANG WU ; Tzeng Y.-S.; Tsai H.-J.; HSIU-PO WANG ; ANN-LII CHENG | Blood Cancer Journal | 34 | 32 | |
37 | 2014 | Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients | Lin Y.-.; YI-HSIN LIANG ; JIA-HUEI TSAI ; JAU-YU LIAU ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 17 | 16 | |
38 | 2013 | Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer | Lin, Yu-Lin; JAU-YU LIAU ; SHAN-CHI YU ; LI-HUI TSENG ; LIANG-IN LIN ; JIN-TUNG LIANG ; BEEN-REN LIN ; JI-SHIANG HUNG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | Translational oncology | 9 | 10 | |
39 | 2013 | Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: Clinical and biological significance | SUNG-HSIN KUO ; Chen L.-T.; CHUNG-WU LIN ; MING-SHIANG WU ; PING-NING HSU ; Tsai H.-J.; Chu C.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; KUN-HUEI YEH ; ANN-LII CHENG | Blood Cancer Journal | 38 | 36 | |
40 | 2013 | No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply | SUNG-HSIN KUO ; Weng W.-H.; KUN-HUEI YEH ; Chen L.-T.; ANN-LII CHENG | Genes Chromosomes and Cancer | 1 | 1 | |
41 | 2013 | erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5) | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH | Gastric Cancer | 0 | 0 | |
42 | 2013 | Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy | WEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU | Anticancer Research | 11 | 11 | |
43 | 2012 | KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | Lin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 43 | 35 | |
44 | 2012 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH | Gastric Cancer | 19 | 18 | |
45 | 2012 | Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas | SUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; PING-NING HSU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG | Blood | 114 | 93 | |
46 | 2012 | Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer | LI-CHUN LU ; YU-YUN SHAO ; CHIH-HUNG HSU ; CHIUN HSU ; WEN-FANG CHENG ; YU-LIN LIN ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 0 | ||
47 | 2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG | European Journal of Cancer | 17 | 17 | |
48 | 2011 | T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement | SUNG-HSIN KUO ; ANN-LII CHENG ; CHUNG-WU LIN ; CHIH-HUNG HSU ; MING-SHIANG WU ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen L.-T. | Cancer Chemotherapy and Pharmacology | 13 | 8 | |
49 | 2011 | Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers | Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG ; KUN-HUEI YEH | Anti-Cancer Drugs | 4 | 3 | |
50 | 2011 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan | Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG ; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH ; Chen L.-T.; Whang-Peng J. | Cancer Chemotherapy and Pharmacology | 6 | 5 | |
51 | 2011 | Recent advances in the treatment of metastatic colorectal cancer in Taiwan | Lin Y.-L.; KUN-HUEI YEH ; ANN-LII CHENG | Journal of the Formosan Medical Association | 1 | 1 | |
52 | 2011 | Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma | SUNG-HSIN KUO ; Weng W.-H.; Chen Z.-H.; PING-NING HSU ; MING-SHIANG WU ; CHUNG-WU LIN ; Jeng H.-J.; KUN-HUEI YEH ; Tsai H.-J.; Chen L.-T.; ANN-LII CHENG | Genes Chromosomes and Cancer | 7 | 9 | |
53 | 2010 | Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation | PO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH | Anticancer Research | 6 | 4 | |
54 | 2009 | EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment | Huang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 43 | 36 | |
55 | 2008 | Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells | Chen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG | Cancer Research | 114 | 105 | |
56 | 2008 | Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma | SUNG-HSIN KUO ; Yeh P.-Y.; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; Tzeng Y.-S.; Chen J.-Y.; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG | Blood | 46 | 47 | |
57 | 2008 | Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment | SUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; KUAN-TING KUO ; Yeh P.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG | Annals of Surgery | 14 | 13 | |
58 | 2008 | Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation | TA-CHEN HUANG ; KUN-HUEI YEH ; ANN-LII CHENG ; CHIH-HUNG HSU | Anticancer Research | 15 | 9 | |
59 | 2007 | Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression | SUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; KUAN-TING KUO ; KUN-HUEI YEH ; SHIN-LIAN DOONG ; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; CHUNG-WU LIN ; Lin J.-T.; ANN-LII CHENG | Journal of Pathology | 19 | 11 | |
60 | 2007 | Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; JANG-MING LEE ; KUN-HUEI YEH ; CHIH-HSIN YANG ; Lin J.-T.; ANN-LII CHENG ; Lee Y.-C. | Annals of Oncology | 39 | 36 | |
61 | 2007 | Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma | CHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU | Anti-Cancer Drugs | 10 | 8 | |
62 | 2007 | A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer | CHIA-CHI LIN ; ANN-LII CHENG ; CHIH-HUNG HSU ; YEN-SHEN LU ; CHIUN HSU ; KUN-HUEI YEH ; Wu C.-Y.; CHIUN-SHENG HUANG ; CHIH-HSIN YANG | Anticancer Research | 2 | 2 | |
63 | 2006 | A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus | Pei Y.Y.; SUNG-HSIN KUO ; KUN-HUEI YEH ; Chuang S.-E.; CHIH-HUNG HSU ; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG | Journal of Biological Chemistry | 43 | 39 | |
64 | 2006 | An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer | Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH ; Kao W.Y.; Chen L.T.; ANN-LII CHENG | British Journal of Cancer | 13 | 13 | |
65 | 2005 | Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21) | KUN-HUEI YEH ; SUNG-HSIN KUO ; Chen, Li-Tzong; TSUI-LIEN MAO ; SHIN-LIAN DOONG ; MING-SHIANG WU ; Hsu, Hui-Chen; Tzeng, Yi-Shin; Chen, Chi-Long; JAW-TOWN LIN ; ANN-LII CHENG | Blood | 71 | 59 | |
66 | 2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer | KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.-F.; CHIUN HSU ; SUNG-HSIN KUO ; Li Jr. S.; ANN-LII CHENG | Oncology | 22 | 22 | |
67 | 2005 | Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG | World Journal of Gastroenterology | 26 | 25 | |
68 | 2005 | Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer | KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG | British Journal of Cancer | 7 | 7 | |
69 | 2005 | Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma | SUNG-HSIN KUO ; Chen L.-T.; Chen C.-L.; SHIN-LIAN DOONG ; KUN-HUEI YEH ; MING-SHIANG WU ; TSUI-LIEN MAO ; Hsu H.-C.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG | World Journal of Gastroenterology | 15 | 15 | |
70 | 2005 | Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung | KUN-HUEI YEH ; Shiou-Hwei Yeh ; Wan J.-P.; Ying-Chun Shen ; ANN-LII CHENG | Anti-Cancer Drugs | 4 | 3 | |
71 | 2005 | Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment | CHIH-HSIN YANG ; Chen M.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Yu Y.-C.; Whang-Peng J.; PAN-CHYR YANG | Oncology | 5 | 4 | |
72 | 2004 | Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer | Chao Y.; KUN-HUEI YEH ; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG | British Journal of Cancer | 72 | 63 | |
73 | 2004 | Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract | CHIUN HSU ; Ying-Chun Shen ; CHIH-HSIN YANG ; KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG | British Journal of Cancer | 42 | 40 | |
74 | 2004 | Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation | Yeh P.Y.; KUN-HUEI YEH ; Chuang S.-E.; Song Y.C.; ANN-LII CHENG | Journal of Biological Chemistry | 96 | 90 | |
75 | 2004 | Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells | KUN-HUEI YEH ; ANN-LII CHENG ; Wan J.-P.; Lin C.-S.; Liu C.-C. | Anti-Cancer Drugs | 37 | 33 | |
76 | 2004 | Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas | SUNG-HSIN KUO ; Chen L.-T.; KUN-HUEI YEH ; MING-SHIANG WU ; Hsu H.-C.; Yeh P.-Y.; TSUI-LIEN MAO ; Chen C.-L.; SHIN-LIAN DOONG ; Lin J.-T.; ANN-LII CHENG | Journal of Clinical Oncology | 63 | 53 | |
77 | 2004 | Recent advances in therapy for gastric cancer | KUN-HUEI YEH ; ANN-LII CHENG | Journal of the Formosan Medical Association | 7 | 7 | |
78 | 2004 | Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma | Lu Y.-S.; CHIUN HSU ; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIH-HUNG HSU ; Wu C.-Y.; ANN-LII CHENG | Hepato-Gastroenterology | 14 | 13 | |
79 | 2004 | Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG | Oncogene | 68 | 69 | |
80 | 2003 | High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma | KUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG | Anticancer Research | 3 | 3 | |
81 | 2003 | Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; ANN-LII CHENG | Biochemical Pharmacology | 37 | 31 | |
82 | 2002 | Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma | Huang C.-L.; ZHONG-ZHE LIN ; Su I.-J.; Chao T.-Y.; HWEI-FANG TIEN ; Chang M.-C.; Huang M.-C.; Kao W.-Y.; JIH-LUH TANG ; KUN-HUEI YEH ; Wang C.-H.; CHIH-HUNG HSU ; Liu M.-Y.; ANN-LII CHENG | Leukemia and Lymphoma | 9 | 5 | |
83 | 2002 | High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection | JIN-TUNG LIANG ; KUO-CHIN HUANG ; HONG-SHIEE LAI ; PO-HUANG LEE ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; Tang C.; KING-JEN CHANG | International Journal of Cancer | 109 | 98 | |
84 | 2002 | P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection | JIN-TUNG LIANG ; KUO-CHIN HUANG ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; KING-JEN CHANG | International Journal of Cancer | 66 | 57 | |
85 | 2002 | A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil | CHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; CHIH-HSIN YANG ; YEN-SHEN LU ; CHIA-CHI LIN ; Bu C.-F.; KUN-HUEI YEH | Anticancer Research | 12 | 12 | |
86 | 2002 | Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Song Y.C.; Ea C.-K.; ANN-LII CHENG | Biochemical Pharmacology | 130 | 128 | |
87 | 2001 | Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin | Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH ; Chyi Song Y.; ANN-LII CHENG | Biochemical and Biophysical Research Communications | 34 | 35 | |
88 | 2000 | Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil | KUN-HUEI YEH ; Shiou-Hwei Yeh ; CHIH-HUNG HSU ; TONG-MEI WANG ; Ma I.-F.; ANN-LII CHENG | British Journal of Cancer | 26 | ||
89 | 2000 | Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assay | KUN-HUEI YEH ; Shiou-Hwei Yeh ; Chang Y.-S.; ANN-LII CHENG | Pharmacology and Toxicology | 15 | 12 | |
90 | 1999 | High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma | CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHONG-JEN YU ; Lin J.-F.; PAN-CHYR YANG | Cancer | 23 | ||
91 | 1999 | Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil | CHIH-HUNG HSU ; KUN-HUEI YEH ; Lui L.T.; Lee Y.-C.; Bu C.-F.; HSIU-PO WANG ; Lin J.-T.; ANN-LII CHENG | Anticancer Research | 29 | 26 | |
92 | 1999 | Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma | KUN-HUEI YEH ; HUANG-CHUN LIEN ; Hsu S.-M.; ANN-LII CHENG | American Journal of Hematology | 31 | ||
93 | 1999 | Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy | KUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG | Hepato-Gastroenterology | 23 | 24 | |
94 | 1998 | Gastric cancer associated with acute disseminated intravascular coagulation: Successful initial treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin | KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Haematology | 40 | 35 | |
95 | 1998 | Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen | ANN-LII CHENG ; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH ; Liao C.-M.; Lay J.-D.; Chen D.-S. | Biochemical Pharmacology | 69 | 65 | |
96 | 1998 | Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol | ANN-LII CHENG ; KUN-HUEI YEH ; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H. | Cancer | 61 | ||
97 | 1998 | High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy | KUN-HUEI YEH ; CHIA-TUNG SHUN ; Chen C.-L.; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG | Cancer | 105 | ||
98 | 1998 | Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer | ANN-LII CHENG ; KUN-HUEI YEH ; Lin J.-T.; CHIUN HSU ; Liu M.-Y. | Anticancer Research | 23 | 20 | |
99 | 1998 | Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma | ANN-LII CHENG ; KUN-HUEI YEH ; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; DING-SHINN CHEN | Hepato-Gastroenterology | 41 | 33 | |
100 | 1998 | Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19) - Possible clinical significance in advanced gastric cancer | KUN-HUEI YEH ; YAO-CHANG CHEN ; Shiou-Hwei Yeh ; Chen C.-P.; Lin J.-T.; ANN-LII CHENG | Anticancer Research | 46 | 43 | |
101 | 1998 | Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers | KUN-HUEI YEH ; Chen C.-L.; CHIA-TUNG SHUN ; Lin J.-T.; Lee W.-J.; PO-HUANG LEE ; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of Clinical Gastroenterology | 15 | 12 | |
102 | 1998 | Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity (multiple letters) [1] | Valik D.; KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Cancer | 3 | 5 | |
103 | 1998 | High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers | KUN-HUEI YEH ; Lin M.-T.; Lin D.-T.; JIH-LUH TANG ; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG ; Yu S.-C.; KING-JEN CHANG ; YAO-CHANG CHEN | Breast Cancer Research and Treatment | 2 | 2 | |
104 | 1997 | Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers | CHIH-HUNG HSU ; KUN-HUEI YEH ; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Oncology (Switzerland) | 60 | 51 | |
105 | 1997 | Thymic carcinoma with autoimmune syndrome: Successful treatment with weekly infusional high-dose 5-fluorouracil and leucovorin | CHIH-HUNG HSU ; KUN-HUEI YEH ; ANN-LII CHENG | Anticancer Research | 18 | 17 | |
106 | 1997 | MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer | CHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association | 4 | 3 | |
107 | 1997 | A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers | KUN-HUEI YEH ; ANN-LII CHENG ; Lin M.-T.; RUEY-LONG HONG ; CHIH-HUNG HSU ; Lin J.-F.; KING-JEN CHANG ; PO-HUANG LEE ; YAO-CHANG CHEN | Anticancer Research | 32 | 27 | |
108 | 1997 | High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung | KUN-HUEI YEH ; ANN-LII CHENG | Anticancer Research | 14 | 11 | |
109 | 1997 | Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas | KUN-HUEI YEH ; ANN-LII CHENG ; Su I.H.-J.; Lin M.-T.; HWEI-FANG TIEN ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Anticancer Research | 20 | 14 | |
110 | 1997 | High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2] | KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Cancer | 124 | 97 | |
111 | 1996 | Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma | ANN-LII CHENG ; YAO-CHANG CHEN ; KUN-HUEI YEH ; Chuang S.-E.; Chen B.-R.; DING-SHINN CHEN | Cancer | 37 | ||
112 | 1995 | Primary T cell leptomeningeal lymphoma – Successful treatment with systemic chemotherapy | KUN-HUEI YEH ; ANN-LII CHENG ; HWEI-FANG TIEN | Oncology (Switzerland) | 14 | 9 | |
113 | 1994 | Acute confusion induced by a high-dose infusion of 5-fluorouracil and folinic acid | KUN-HUEI YEH ; ANN-LII CHENG | Journal of the Formosan Medical Association | 16 | 0 | |
114 | 1994 | Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: A pilot study | KUN-HUEI YEH ; ANN-LII CHENG ; Chen Y.-C.; Chen B.-R.; Lee W.-J.; Lin J.-T.; PO-HUANG LEE ; KING-JEN CHANG ; Wang C.-H.; Wang T.-H. | Journal of the Formosan Medical Association | 6 | 0 | |
115 | 1994 | An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2] | KUN-HUEI YEH ; ANN-LII CHENG | Journal of Clinical Oncology | 18 | 16 |